Graphitic carbon nitride, known chemically as g-C3N4, is a polymeric semiconductor composed of carbon and nitrogen arranged in layered sheets reminiscent of graphite. It has attracted intense scientific interest because it is chemically stable, non-toxic, inexpensive, and remarkably easy to synthesize from common nitrogen-rich precursors. Crucially, it absorbs visible light, meaning it can in principle be driven by ordinary sunlight rather than expensive ultraviolet lamps. When photons strike the material, they excite electrons from the valence band to the conduction band, leaving behind positively charged holes. These photogenerated charge carriers can then react with water, oxygen, and dissolved species to produce highly reactive oxidizing agents capable of shredding organic pollutant molecules into harmless fragments.

Yet pristine g-C3N4 suffers from well-documented weaknesses that have kept it out of real-world deployment. Photogenerated electrons and holes recombine rapidly, releasing energy as heat before they can do useful chemical work. The material’s surface is comparatively inert, limiting its ability to adsorb and react with target pollutants, and its visible-light absorption, while real, does not extend deeply enough into the solar spectrum. The Hanoi review systematically examines how researchers have overcome these limitations by constructing hybrid photocatalysts, or CN-HPs, in which g-C3N4 is coupled with other materials to form sophisticated junctions that separate charges, extend light harvesting, and boost surface reactivity.

The strategies catalogued in the review are strikingly diverse. Heterojunctions pair g-C3N4 with metal oxides such as ZnO, TiO2, WO3, and BiVO4, or with more exotic partners including MXenes, layered double hydroxides, perovskites, and metal-organic frameworks. Z-scheme and S-scheme architectures are particularly elegant: they mimic natural photosynthesis by selectively retaining the most energetic electrons and holes on different components while allowing the useless carriers to recombine, thereby preserving strong oxidation and reduction power simultaneously. Doping with elements such as sulfur or phosphorus tunes the electronic structure, while carbon quantum dots and noble metal nanoparticles act as electron sinks and co-catalysts. Magnetic components such as Fe3O4 even allow the catalyst particles to be retrieved from treated water with a simple magnet, addressing one of the classic headaches of nanoparticle-based treatment.

The performance figures reported across the literature are impressive, at least under laboratory conditions. CN-HPs have achieved high removal efficiencies for a wide range of pharmaceutical pollutants, including tetracycline, ciprofloxacin, levofloxacin, oxytetracycline, amoxicillin, sulfamethoxazole, ibuprofen, naproxen, acetaminophen, and the anticancer drug 5-fluorouracil. Many systems operate under visible light or even natural sunlight, and some have been tested in continuous-flow configurations and real hospital or mariculture wastewater matrices. The review emphasizes that these materials also retain their activity over repeated catalytic cycles, a critical requirement for any technology hoping to move from the bench to a treatment plant.

Beneath the headline efficiency numbers lies a more nuanced chemical story. The review details how degradation proceeds through the concerted action of three principal reactive species: superoxide radicals, hydroxyl radicals, and photogenerated holes. Each attacks drug molecules at characteristic bonds, cleaving rings and side chains to produce a cascade of smaller intermediate compounds. Ideally, these intermediates are then progressively mineralized into carbon dioxide, water, and inorganic ions. However, the authors highlight an important caveat that recurs throughout the literature: total organic carbon reduction and complete mineralization typically require substantially more time than the initial disappearance of the parent pollutant. In other words, a water sample may test clean for the original drug while still carrying a cocktail of partially oxidized fragments.

That gap between degradation and detoxification is where the review delivers its most consequential warning. Toxicity assessments show that the by-products formed during photocatalytic degradation can carry toxicity profiles different from, and in some cases potentially greater than, those of the original compounds. High removal efficiency alone, the authors argue, does not demonstrate environmental safety. A treatment system that rapidly converts an antibiotic into unidentified fragments without verifying their ecological impact may simply be trading one hazard for another. The review therefore calls for toxicity evaluation to become a standard, non-negotiable component of photocatalysis research, rather than an optional add-on performed in only a minority of studies.

The authors are equally candid about the obstacles standing between laboratory success and field deployment. Most published experiments use purified water, single pollutants at concentrations far above environmental levels, and idealized light sources. Real wastewater presents a hostile environment: competing organic matter scavenges radicals, suspended solids scatter light, mixtures of drugs interact unpredictably, and pH fluctuates continuously. Long-term environmental safety of the nanomaterials themselves, including potential release of catalyst components into treated water, remains insufficiently characterized. Energy efficiency and the engineering challenge of scaling thin-film or slurry reactors to the volumes handled by municipal plants are also unresolved. The review frames these not as reasons for pessimism but as a well-defined research agenda.

One of the most forward-looking threads in the review concerns artificial intelligence. The authors highlight the potential of combining experimental photocatalysis data with machine learning models to optimize treatment conditions and predict how CN-HP systems will perform against specific target pollutants in the field. Given the enormous design space of possible hybrid materials, dopants, junction types, and operating parameters, data-driven approaches could dramatically accelerate the search for formulations that balance efficiency, stability, cost, and safety. Similar AI-assisted strategies are already gaining traction across membrane design and pollution monitoring, and photocatalysis appears poised to follow the same trajectory.

What emerges from the Hanoi analysis is a technology at an inflection point. The fundamental chemistry works: metal-free, sunlight-driven catalysts can genuinely dismantle the pharmaceutical residues that conventional treatment leaves behind, and they can do so repeatedly and, in many configurations, using abundant and benign raw materials. The remaining task is to prove that this chemistry survives contact with the messy, variable, and economically constrained reality of full-scale water treatment, and that the end products of degradation are demonstrably safe for the ecosystems that receive them. If researchers can close the gap between breaking molecules and proving detoxification, graphitic carbon nitride hybrids may become a cornerstone of the next generation of water purification infrastructure.

Subject of Research: g-C3N4-based hybrid photocatalysts for photocatalytic degradation of emerging pharmaceutical pollutants in water and wastewater

Article Title: g-C3N4-based hybrid photocatalysts for removal of emerging pharmaceutical pollutants from water: recent advances, degradation pathways, toxicity assessment,and future perspectives

Article References: Hanh, D. T. M., & Hoai, P. T. T. (2026). g-C3N4-based hybrid photocatalysts for removal of emerging pharmaceutical pollutants from water: recent advances, degradation pathways, toxicity assessment,and future perspectives. Environmental Geochemistry and Health, 48(16), Article 625. https://doi.org/10.1007/s10653-026-03530-z

Image Credits: AI Generated

DOI: 10.1007/s10653-026-03530-z

Keywords: graphitic carbon nitride, photocatalysis, pharmaceutical pollutants, water treatment, heterojunctions, advanced oxidation processes, degradation pathways, toxicity assessment, antibiotics, mineralization, artificial intelligence, wastewater remediation

In a study published in the journal Crop Health, researchers at Zhejiang University and the Shanghai Academy of Agricultural Sciences combined pot experiments with shotgun metagenomic sequencing to track what happens to albendazole in a soil-earthworm system over 28 days. They spiked farmland soil from Huaian, in Jiangsu Province, with albendazole at 3 milligrams per kilogram, introduced twenty laboratory-cultured Eisenia fetida earthworms into each pot, and then sampled both soil and worm tissue at seven time points. Earthworm mortality stayed below ten percent across all treatments, and high-performance liquid chromatography confirmed that the analytical method recovered between roughly 84 and 102 percent of the spiked compound, giving the team confidence in their residue measurements.

The central discovery is that albendazole does not simply sit inertly in the earthworm gut. Instead, exposure to the drug selectively enriched specific albendazole degradation genes, including hmr and ami, and preferentially activated microbial pathways associated with sulfur reduction, amination of albendazole sulfone, and hydroxylation of the parent compound. In practical terms, the gut microbiome appears to rewire its metabolism to attack the drug molecule, converting it into lower-toxicity metabolites through aminotransferase-mediated amination and side-chain oxidative modification that yields hydroxyalbendazole. Analysis against the KEGG database showed that 21 of 36 microbial metabolic pathways increased in relative abundance under albendazole exposure, and among 3,915 identified enzymes, 2,693 enzyme-coding genes were more abundant in drug-treated worms than in controls.

The metagenomic data went further, identifying which genes were actually doing the biodegradation work. The relative abundances of four biodegradation genes, ppo, xylA, cutC, and nfsl, were between 0.19-fold and 52.64-fold higher in the guts of albendazole-exposed earthworms than in untreated controls. These genes encode functions such as polyphenol oxidase-mediated cleavage of aromatic rings and xylose isomerase-associated cofactor regeneration, both of which are chemically suited to dismantling the benzimidazole scaffold of albendazole. The researchers interpret this selective enrichment as evidence of adaptive evolution: the gut microbial community reshapes itself around the available pollutant, recruiting gene clusters that enhance its capacity to detoxify the xenobiotic.

Perhaps the most striking finding concerns who carries these degradation genes. Through co-occurrence network analysis and metagenome-assembled genome reconstruction, the team identified 83 potential bacterial hosts of biodegradation genes in the earthworm gut. Four genera stood out as dual hosts, carrying both general biodegradation genes and albendazole-specific degradation genes: Sphaerobacter, Saccharothrix, Actinomadura, and Nocardia. In albendazole-treated worms, these dual-functional hosts increased in relative abundance by 0.05 to 1.32-fold compared with controls, and other genera such as Actinomadura, Sphaerobacter, and Saccharothrix rose by as much as 132.63 percent. The dominant gut phyla, Pseudomonadota, Actinomycetota, and Bacillota, together made up more than 95 percent of the community, and albendazole significantly increased overall bacterial diversity in the gut, as measured by the Shannon index.

The study also probed how these degradation genes move between bacteria, a question with real ecological consequences. Horizontal gene transfer, mediated by mobile genetic elements such as plasmids, transposons, and integrons, is the main mechanism by which functional genes spread through microbial communities. The researchers found strong statistical correlations between biodegradation genes and mobile genetic elements, with coefficients of determination ranging from 0.7357 to 0.7888. Yet, counterintuitively, albendazole exposure reduced the abundance of plasmids, transposons, and integrons in the gut by roughly 26 to 36 percent, suggesting that the drug suppresses the horizontal mobility of biodegradation genes even as it enriches the genes themselves within specific host lineages. Some genes, such as bph, a key player in aromatic hydrocarbon degradation, even shifted their genomic context, moving from association with integrases in control worms to plasmids in drug-treated ones.

The experiment had a second, nanotechnological dimension. Zinc oxide nanoparticles, particles between 1 and 100 nanometers that have gained attention for their antimicrobial and catalytic properties, were mixed into the soil at 100 milligrams per kilogram alongside the drug. The results were unambiguous: co-exposure to the nanoparticles significantly reduced albendazole bioaccumulation in the earthworms and accelerated its dissipation in the soil. After 28 days, residual albendazole in earthworm tissue was 0.061 milligrams per kilogram in the drug-only treatment but only 0.031 milligrams per kilogram when nanoparticles were present. The soil half-life of albendazole dropped from 4.70 days to 4.15 days, and final soil residues fell from 0.20 to 0.11 milligrams per kilogram. The bioaccumulation factor declined significantly, indicating that the nanoparticles limit both the environmental persistence of the drug and its uptake by soil organisms.

The mechanism behind the nanoparticle effect remains an open question, but the authors suggest that albendazole may adsorb onto the surface of the zinc oxide particles, reducing its free concentration and bioavailability, while the particles simultaneously stimulate detoxification pathways in the worms. Notably, the nanoparticles showed no significant toxicity to the earthworms at the tested dose and did not disrupt the broader soil bacterial community, addressing a common concern about introducing engineered nanomaterials into agricultural environments. Previous work by other groups has reported that zinc oxide nanoparticles can promote pesticide degradation in soil, and this study extends that observation to a benzimidazole anthelmintic in the presence of living soil fauna.

What makes this research resonate beyond soil chemistry is the picture it paints of the earthworm gut as an active bioremediation engine rather than a passive transit tube. Earthworms are in constant, intimate contact with soil contaminants through their feeding, and their gut microbiomes respond to chemical pressure with remarkable specificity, recruiting both broad-spectrum biodegradation genes and drug-targeted degradation genes in a coordinated detoxification strategy. The researchers propose that genera capable of hosting both gene types may operate synergistically, with albendazole degradation genes preprocessing the substrate for subsequent breakdown by general biodegradation machinery. This functional redundancy, they argue, is a key survival trait in polluted ecosystems, giving microbial communities the resilience to adapt as contaminant levels fluctuate.

The authors are careful to note the limits of the current work. The specific metabolic intermediates of albendazole breakdown, such as albendazole sulfoxide and albendazole sulfone, still require direct confirmation by high-resolution mass spectrometry, and future studies will employ metatranscriptomics and quantitative PCR to verify that the enriched genes are actively expressed rather than merely present. Even so, the findings open a concrete path toward bioremediation strategies for drug-contaminated soils, whether by managing earthworm populations in agricultural fields, harnessing the identified bacterial genera such as Microvirga, Methylobacterium, and Nocardia as inoculants, or deploying zinc oxide nanoparticles as degradation accelerators. In an era when pharmaceutical residues are increasingly recognized as pervasive environmental contaminants, the humble earthworm gut has emerged as an unexpectedly sophisticated chemical factory, one that farmers and ecologists may soon learn to put to work.

Subject of Research: Earthworm gut microbiome-mediated biodegradation of the anthelmintic drug albendazole in soil

Article Title: Earthworm gut microbiome promotes biodegradation of albendazole in soil

Article References: Earthworm gut microbiome promotes biodegradation of albendazole in soil. (n.d.). https://doi.org/10.1007/s44297-026-00068-5

Image Credits: AI Generated

DOI: 10.1007/s44297-026-00068-5

Keywords: albendazole, earthworm gut, microbiome, biodegradation, soil, metagenomics, zinc oxide nanoparticles, bioremediation, mobile genetic elements, horizontal gene transfer, Eisenia fetida, pesticide residues